Your browser doesn't support javascript.
loading
Analysis of severe adverse effects following community-based ivermectin treatment in the Democratic Republic of Congo.
Makenga Bof, Jean-Claude; Muteba, Daniel; Mansiangi, Paul; Ilunga-Ilunga, Félicien; Coppieters, Yves.
Afiliação
  • Makenga Bof JC; School of Public Health, Université Libre de Bruxelles (ULB), Route de Lennik numéro 808 à 1070, Brussels, Belgium. jcmakebof@yahoo.fr.
  • Muteba D; National Program for Onchocerciasis Control (NPOC), Kinshasa, Gombe, Democratic Republic of Congo.
  • Mansiangi P; School of Public Health, Faculty of Medicine, Université de Kinshasa (UNIKIN), Route de Kimwenza, Lemba, Kinshasa, Democratic Republic of Congo.
  • Ilunga-Ilunga F; School of Public Health, Université Libre de Bruxelles (ULB), Route de Lennik numéro 808 à 1070, Brussels, Belgium.
  • Coppieters Y; Institut Supérieur des Techniques Médicales (ISTM), Route de Kimwenza, Lemba, Kinshasa, Democratic Republic of Congo.
BMC Pharmacol Toxicol ; 20(1): 49, 2019 08 16.
Article em En | MEDLINE | ID: mdl-31420005
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ivermectina / Filaricidas Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ivermectina / Filaricidas Idioma: En Ano de publicação: 2019 Tipo de documento: Article